CClinicalTrials.gg
Not yet recruitingNCT07070310DeliVeriNNUpdated Jul 22, 2025

DELirium, Incidence, preVEntion and pRogression During Acute Intensive Neurological -Neurosurgical Rehabilitation

An observational study in Neurological Conditions, sponsored by Heart Centre Rotenburg. Not yet recruiting at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-22.

Sponsored by Heart Centre Rotenburg · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
210
Ages
18 Years and older
Sex
All
01

Study summary

In this longitudinal cohort study the incidence of delirium is assessed for all patients being admitted to the acute intensive neurological-neurosurgical rehabilitation over 3 years. Delirium assessment will be performed daily from admission to discharge. Patients will be divided into 3 groups, according to the presentation of delirium on admission, during the course or not any during the stay in acute rehabilitation and compared regarding the treatment and outcome.

02

Conditions studied

  • Neurological Conditions
03

In context

Lead sponsor

Heart Centre Rotenburg is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients in Neurosurgical rehabilitation

Inclusion criteria

  • Any patient admitted to acute neurological-seurosurgical rehabilitation

Exclusion criteria

Exclusion Criteria:

  • : patients with level of consciousness of coma or vegetative state
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
210 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. incidence of delirium

    Time frame: 3 years

07

Study locations

1 site
  • Herz-Kreislauf-Zentrum Klinikum Hersfeld Rotenburg GmbH, Klinik für Neurologie und Neurologische Rehabilitation
    Rotenburg an der Fulda, 36199, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 22, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07070310
Lead sponsor
Heart Centre Rotenburg
Responsible party
Ralf Degenhardt, PhD (Head of Clinical Research Institute, Heart Centre Rotenburg) — Principal investigator
First posted
Jul 17, 2025
Start date
Aug 15, 2025 (estimated)
Primary completion
Aug 15, 2028 (estimated)
Completion
Feb 15, 2029 (estimated)
Last update
Jul 22, 2025

Study contacts

Caroline Renner, Priv.-Doz. Dr. med
Contact
c.renner@hkz-rotenburg.de
+49-6623-88-0

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion